MWB lifted its target for Drägerwerk stock to EUR 130.00

Published on 10/08/2026 at 13:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Drägerwerk stock traded at EUR 110.90 on October 8, 2026, versus EUR 113.00. The 2026 EBIT margin outlook is 5.0 to 7.5 percent.

Aquarellmalerei der Lübecker Altstadt mit Holstentor und Flussreflexionen in Pastellfarben — Drägerwerk AG & Co. KGaA Firmensitz Lübeck historische Altstadt Holstentor Aquarellmalerei Trave DE0005550636, Illustration mit AI erstellt.

Drägerwerk stock was at EUR 110.90 at Lang & Schwarz on October 8, 2026 at 1:00 p.m. CEST, down 1.86 percent versus the EUR 113.00 prior close. In a report dated September 8, 2026, Finanztrends said MWB Research had raised its Drägerwerk target from EUR 114.00 to EUR 130.00 at the end of August.

Target rises as margins improve

The revised target gives the analyst view a concrete benchmark, but the stock was still EUR 19.10 below that level at the Lang & Schwarz price. The implied gap between EUR 110.90 and EUR 130.00 is 17.22 percent, calculated against the current euro price.

The operating backdrop provides the reason for the debate. Boerse Online reported that second-quarter 2026 revenue reached EUR 847.30 million and that the EBIT margin improved from 2.60 percent to 5.40 percent.

Guidance leaves a wide margin band

Drägerwerk's 2026 outlook is less precise than the analyst target. The company's investor-relations page sets currency-adjusted revenue growth at 2.0 to 6.0 percent and the EBIT margin at 5.0 to 7.5 percent, while its DVA outlook spans EUR 20.00 million to EUR 120.00 million, according to Dräger.

That range makes execution the central issue for the stock. The upper EBIT margin case is 2.50 percentage points above the lower case, so quarterly revenue quality and cost control matter alongside demand.

Stock remains below its yearly high

At EUR 110.90, Drägerwerk stock stood EUR 14.50 below its 52-week high of EUR 125.40 on October 8, 2026, a 11.56 percent discount. Its market capitalization was EUR 2.1 billion on the same date, and the 52-week range extended down to EUR 64.90.

The next scheduled reporting date is October 29, 2026, when the third-quarter figures are due, as stated in the September 8, 2026 report by Finanztrends. The result will test whether the stronger second-quarter margin can support the upper half of the 2026 outlook.

Price points to the next test

Drägerwerk stock was trading at EUR 110.90 at Lang & Schwarz on October 8, 2026 at 1:00 p.m. CEST, compared with the EUR 113.00 prior close on October 7, 2026. The primary listing is Xetra, where the company is included in the TecDAX and SDAX.

The further course of trading is shown by the continuously updated real-time quote of Drägerwerk stock.